APA (7th ed.) Citation

H, v. B., G, O., N, E., T, T., M, A., R, S., . . . S, Y. (2026). Non-ICANS neurologic toxicity after BCMA CAR-T therapy: A systematic review and meta-analysis of 4630 patients with multiple myeloma. Blood advances, 10(15), 5413. https://doi.org/10.1182/bloodadvances.2026019617

Chicago Style (17th ed.) Citation

H, van Besien, Ozkan G, Easton N, Tix T, Alhomoud M, Shouval R, Rejeski K, and Yamshon S. "Non-ICANS Neurologic Toxicity After BCMA CAR-T Therapy: A Systematic Review and Meta-analysis of 4630 Patients with Multiple Myeloma." Blood Advances 10, no. 15 (2026): 5413. https://doi.org/10.1182/bloodadvances.2026019617.

MLA (9th ed.) Citation

H, van Besien, et al. "Non-ICANS Neurologic Toxicity After BCMA CAR-T Therapy: A Systematic Review and Meta-analysis of 4630 Patients with Multiple Myeloma." Blood Advances, vol. 10, no. 15, 2026, p. 5413, https://doi.org/10.1182/bloodadvances.2026019617.